Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -10.00 (-3.67%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £78.94m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Trading Update

1 Jul 2025 07:00

RNS Number : 0865P
Mpac Group PLC
01 July 2025
 

1 July 2025

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"), AND IS DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF MAR. 

 

 

Mpac Group plc

(''Mpac'' or the "Group")

 

Trading update, consolidation of US footprint, and notice of results

 

Q2 order intake impacted by tariff uncertainty causing deferral of order decisions which will impact H2 revenue

 

Slower market conditions allow opportunity to accelerate US consolidation plans and optimise cost base for when conditions improve

 

Mpac Group plc, a global leader in high-speed packaging and automation solutions, issues a trading update ahead of the release of its unaudited results for the six months ended 30 June 2025.

 

Revenue in the first half was in line with the Board's expectations, despite the growing macro-economic headwinds resulting from US tariffs. A strong January order book, good performance from the businesses acquired in the prior year, and healthy short-cycle service business all contributed to an H1 operating performance in line with management expectations.

 

However, Original Equipment ("OE") order intake in the core Mpac business (excluding the 2024 acquisitions) has slowed materially through Q2, as customers responded to growing uncertainty around tariffs and low consumer confidence by deferring capital investments and cutting back on spending. The closing order book at 30 June is expected to be circa £90.0m (Dec 2024: £118.5m), providing materially lower than anticipated cover for H2 revenue, with the Americas region particularly impacted. Our services business has remained broadly unaffected, and both of the 2024 acquisitions (BCA and CSi) continue to trade well and in line with management expectations, with CSi specifically benefiting from limited exposure to the US.

 

Q2 order intake is an important period for the Group as orders secured in the period drive H2 revenue flow to where there is typically a natural full year weighting. Accordingly, due to the expected impact from slower orders in Q2 the Board now expects FY 2025 revenue to fall significantly below the Board's previous expectations.

 

Given the current slower market conditions in the US, the Board has decided to take the opportunity to accelerate its plans to consolidate its operational footprint in the US, optimising capacity and the cost base. The Group's facility in Cleveland Ohio will be closed, consolidating it with the business acquired in 2024 in Boston Massachusetts improving utilisation rates. The Group is also reducing capacity in Mississauga Canada. No impact on customers is anticipated. The restructuring will incur non-cash impairment charges in the region of £11.5m.

 

This and other cost saving measures have been designed to maintain existing operating margins despite the reduction in revenue, offsetting the impact of reduced operational leverage. This will further provide a more efficient baseline cost for future growth when global markets improve.

 

The shortfall in customer deposits arising from reduced OE orders also has the effect of marginally increasing June 2025 net debt compared to closing net debt from Dec 2024. Actions to reduce debt have been taken, which include implementing new controls to improve operational efficiency and cash milestone delivery, re-negotiate customer and supplier terms, reduce capital expenditure and minimise discretionary spend. The Group expects to remain comfortably within its covenants.

 

Positively, the Group is also announcing today a 'buy in' transaction for its UK defined benefit pensions scheme and further detail will be set out in a separate announcement. This will help simplify the Group's balance sheet and eliminate a significant risk to Mpac's future profitability and cash flow.

 

The Group expects to announce its unaudited results for the six months ended 30 June 2025 on 23 September 2025.

 

Adam Holland, Chief Executive Officer, commented:

 

"During the later part of the first half of 2025 we have seen the impact of US trade tariffs, falling consumer confidence, and growing economic uncertainty. Customers have increasingly chosen to defer capital investment decisions, with the Americas region being at the epicentre with other regions less impacted to date. Despite resilient first half revenues, the slow down in order intake through H1 2025 means that we must take prompt action now, in anticipation of lower full year revenues and profit than previously expected.

 

Today we announce the restructuring of our US operations, combining two operational sites into a single, more efficient operation in Boston Massachusetts, and reducing capacity in Mississauga Canada.

 

The slowdown of orders and customer deposits has also impacted cash, and net debt rose during the first half of the year. Appropriate control measures have has been implemented to slow and reverse this movement.

 

The actions we take today to simplify our business in response to challenging conditions sets a direction of travel that will position the Group for future growth when markets recover."

 

  

For further information, please contact:

Mpac Group plc

Adam Holland, Chief Executive Officer

Will Wilkins, Chief Financial Officer

Tel: +44(0)24 7642 1100

Shore Capital (Nominated Adviser & Broker)

Advisory

Patrick Castle/Sophie Collins

Broking

Henry Willcocks

 

 

Tel: +44(0)20 7408 4050

 

Panmure Liberum (Joint Broker)

Edward Mansfield

Will King

Freddie Wooding

 

Hudson Sandler

Nick Lyon

Nick Moore

Tel: +44 (0) 20 3100 2000

 

 

 

 

Tel: +44 (0) 20 7796 4133

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTWPUUGQUPAPUU
Date   Source Headline
16th Jul 201911:07 amRNSSecond Price Monitoring Extn
16th Jul 201911:01 amRNSPrice Monitoring Extension
16th Jul 20197:00 amRNSTrading Update
12th Jun 20193:30 pmRNSAwards under Long Term Incentive Plan
11th Jun 20197:00 amRNSPension scheme valuation update
3rd May 20193:15 pmRNSDirector/PDMR Shareholding
3rd May 20191:23 pmRNSTR-1
3rd May 20191:19 pmRNSAwards under Deferred Share Plan
2nd May 20194:14 pmRNSResult of AGM
1st May 20197:00 amRNSAcquisition of Lambert and Trading Update
3rd Apr 20193:57 pmRNSPosting of 2018 Annual Report and Notice of AGM
5th Mar 20197:00 amRNSFinal results for the year ended 31 December 2018
30th Jan 20197:00 amRNSNotice of Results
7th Jan 20197:00 amRNSYear-end trading update
1st Nov 20187:00 amRNSDirectorate Appointment
6th Sep 20185:21 pmRNSDirector/PDMR Shareholding
6th Sep 20184:41 pmRNSSecond Price Monitoring Extn
6th Sep 20184:36 pmRNSPrice Monitoring Extension
6th Sep 20187:00 amRNSHalf-year results
20th Aug 201810:55 amRNSNotice of Results - Replacement
3rd Aug 201811:30 amRNSNotice of Results
18th Jul 20185:49 pmRNSHolding(s) in Company
18th Jul 201811:06 amRNSSecond Price Monitoring Extn
18th Jul 201811:01 amRNSPrice Monitoring Extension
18th Jul 20187:00 amRNSHalf- Year Trading Update
22nd Jun 20187:00 amRNSDirectorate Change
3rd May 20185:12 pmRNSDirectorate Change
19th Apr 20182:07 pmRNSResult of AGM and Board Changes
19th Apr 20187:00 amRNSAGM statement and Board Change
21st Mar 201810:02 amRNSPosting of 2017 Annual Report and Notice of AGM
16th Mar 201811:38 amRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNSFinal Results for the year to 31 December 2017
14th Feb 20187:00 amRNSNotice of Results
26th Jan 20187:00 amRNSChange of name to Mpac Group plc
22nd Jan 201811:11 amRNSResult of General Meeting and Change of Name
3rd Jan 201812:28 pmRNSProposed name change and notice of General Meeting
2nd Jan 20184:20 pmRNSDisposal
5th Dec 20177:00 amRNSDisposal
10th Oct 20173:39 pmRNSChange of Registered Office
14th Sep 201711:16 amRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSHalf-year Report
1st Sep 201712:05 pmRNSDirectorate Change
22nd Aug 201710:31 amRNSNotice of Half Year Results
1st Aug 20172:50 pmRNSCompletion of disposal
12th Jul 20177:00 amRNSDirectorate Change
29th Jun 20179:14 amRNSHolding(s) in Company
27th Jun 20172:33 pmRNSResult of General Meeting
27th Jun 20177:00 amRNSHalf-Year Trading Update
16th Jun 20174:36 pmRNSDirector/PDMR Shareholding
9th Jun 20177:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.